Authors
Latest:
Expert highlights cybersecurity regulation updates for health care organizationsThere have been several recent regulatory updates related to cybersecurity in health care.
Latest:
iRARC adoption is slow but persistent in bladder cancer"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.
Latest:
Going “retro”: A perspective on robotic retroperitoneal renal surgeryImprovements in technology have renewed interest in the technique.
Latest:
Strategies to mitigate impact of intravenous ICM shortage"The global shortage of ICM has necessitated rapid adaptation of workflows and clinical pathways, which are particularly important for practicing urologists who are evaluating patients for hematuria," write Yair Lotan, MD, and colleagues.
Latest:
FDA approves niraparib/abiraterone tablet for BRCA-positive mCRPCThe approval of the niraparib/abiraterone dual-action tablet for BRCA-positive mCRPC is based on findings from the phase 3 MAGNITUDE study.
Latest:
Asked by a Resident: Dr. Efe Chantal Ghanney Simons interviews Dr. Mark S. Litwin"The most important thing I feel I've learned in my life so far is the value of human interaction and human connection," says Mark S. Litwin, MD, MPH.
Latest:
Future Directions in Imaging for Patients With Prostate CancerClosing out his review of imaging modalities in the setting of prostate cancer, Brian Helfand, MD, PhD, looks toward future evolutions in detection and treatment.
Latest:
Multidisciplinary Care in Prostate CancerIn the second article of this series, Ryan A. Hankins, MD, and Sean P. Collins, MD, PhD, discuss multidisciplinary care practices in prostate cancer, with a focus on communication across specialties.
Latest:
Urologic implications of Lynch syndromeResearch indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.
Latest:
What is genetic discrimination, and why does it matter?Fear of discrimination has downstream effects on health care.
Latest:
Expert shares advice for ethical adoption of AI in health care“Responsible application of AI is crucial, especially when the health and well being of people are at stake,” writes industry expert Manny Krakaris.
Latest:
Is now a good time to sell your medical practice to a private equity group?Industry expert provides in-depth advice.
Latest:
Strategies for dealing with difficult patientsIn this article, an expert addresses the most common issues that come up with patients that may make them harder to deal with and solutions that may help a provider.
Latest:
Management of hormone-naïve oligometastatic prostate cancerGrowing evidence supports the existence of an intermediate metastatic disease state.
Latest:
Drug interactions to monitor when prescribing erectile dysfunction medicationsMany of the medications used in the treatment of ED have interactions with other medications, so it is crucial to carefully examine patient profiles to optimize therapy and ensure safety.
Latest:
Michigan Institute of Urology (MIU) joins Solaris Health, nation's largest urological services providerMIU seizes innovation opportunities presented by dynamic national urology platform caring for nearly one-half million patients.
Latest:
The safety and oncologic benefits of transperineal vs transrectal MRI-guided prostate biopsy"These studies, taken together, offer important insight into the direction we should be heading in prostate cancer diagnosis: toward a targeted-only TP biopsy," write Tarik Benidir, MD, and Zeyad Schwen, MD.
Latest:
Urologic implications of Lynch syndromeResearch indicates Lynch syndrome is associated with urothelial, prostate, and other urologic cancers.
Latest:
Northwestern Urology offers several free online CME coursesThe Northwestern Medicine Department of Urology provides no-cost continuing medical education programs for urology professionals.
Latest:
Encouraging antitumor activity seen with neoadjuvant enfortumab vedotin in patients with cisplatin-ineligible MIBC“This first disclosure of data supports the ongoing phase 2 and 3 programs evaluating enfor-tumab vedotin alone or in combination with pembrolizumab in MIBC,” said Daniel P. Petrylak, MD.
Latest:
Update offers clues to optimal olaparib use in prostate cancerThe latest findings for the PARP inhibitor in prostate cancer come from an analysis of the pivotal phase 3 PROfound trial presented during the 2021 AUA Annual Meeting.
Latest:
Coaching program aims to alleviate female physician burnoutCofounders Adrienne Mann, MD, and Tyra Fainstad, MD, discuss Better Together, a professional, structured coaching program designed to address the burnout experienced by women in medicine.
Latest:
AUGS Research AgendaTo acknowledge the need for increased research funding directed towards women’s health, beyond maternity and reproductive care, AUGS has established the National Urogynecology Research Agenda.
Latest:
Radium-223 yields OS of approximately 18 months in mCRPC“Our observations in this study show that radium-223 can be integrated into the treatment sequence for patients with (metastatic castration-resistant prostate cancer),” said Daniel Y. Song, MD.
Latest:
Diversity in Urology: Progress made, but there is more work to be doneKelvin Moses, MD, PhD, interviews Tracy M. Downs, MD, about progress and remaining challenges regarding diversity, equity, and inclusion in the field of urology.
Latest:
Everything you need to know about medical coding and billing auditsThrough medical claims audits, the practice can help protected itself against fraudulent billing activity and claims.
Latest:
Overview of Advanced/Metastatic Prostate CancerIn the first article of this series, Nilay Gandhi, MD, explains the treatment and management of patients with advanced/metastatic prostate cancer and details the options for androgen deprivation therapy.
Latest:
Tips for physicians to improve work-life balanceOverworking has become the norm, but that doesn’t mean it should be.
Latest:
Case report details spontaneous bladder rupture caused by herpes zoster–associated urinary retentionAlthough cases of acute urinary retention and defecation caused by herpes zoster in the sacral area have been reported, no clinical cases about spontaneous bladder rupture have been previously published, according to the authors.
